Armata Pharmaceuticals, Inc. (FRA:TG1N)
5.15
+0.15 (3.00%)
At close: Jan 23, 2026
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of €205.31 million as of January 30, 2026. Its market cap has increased by 191.44% in one year.
Market Cap
205.31M
Enterprise Value
342.45M
Revenue
4.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.15
Market Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from 41.20M to 205.31M, an increase of 398.37%. That is a compound annual growth rate of 26.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 205.31M | 5.44% |
| Dec 31, 2025 | 194.73M | 201.18% |
| Dec 31, 2024 | 64.66M | -38.98% |
| Dec 29, 2023 | 105.95M | 152.65% |
| Dec 30, 2022 | 41.94M | -67.87% |
| Dec 31, 2021 | 130.52M | 186.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EUWAX Aktiengesellschaft | 257.50M |
| centrotherm international AG | 241.25M |
| STINAG Stuttgart Invest AG | 232.23M |
| Sino AG | 228.14M |
| ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft | 208.56M |
| Allane SE | 206.12M |
| Eleving Group | 197.91M |
| ADM Hamburg Aktiengesellschaft | 173.72M |